Navigation Links
Studies find new links between sleep duration and depression
Date:1/31/2014

DARIEN, IL A genetic study of adult twins and a community-based study of adolescents both report novel links between sleep duration and depression. The studies are published in the Feb. 1 issue of the journal Sleep.

"Healthy sleep is a necessity for physical, mental and emotional well-being," said American Academy of Sleep Medicine President Dr. M. Safwan Badr. "This new research emphasizes that we can make an investment in our health by prioritizing sleep."

A study of 1,788 adult twins is the first to demonstrate a gene by environment interaction between self-reported habitual sleep duration and depressive symptoms. Results suggest that sleep durations outside the normal range increase the genetic risk for depressive symptoms. Among twins with a normal sleep duration of seven to 8.9 hours per night, the total heritability of depressive symptoms was 27 percent. However, the genetic influence on depressive symptoms increased to 53 percent among twins with a short sleep duration of five hours per night and 49 percent among those who reported sleeping 10 hours per night.

"We were surprised that the heritability of depressive symptoms in twins with very short sleep was nearly twice the heritability in twins sleeping normal amounts of time," said principal investigator Dr. Nathaniel Watson, associate professor of neurology and co-director of the University of Washington Medicine Sleep Center in Seattle, Wash. "Both short and excessively long sleep durations appear to activate genes related to depressive symptoms," added Watson, who also serves on the board of directors of the American Academy of Sleep Medicine.

According to Watson, the study suggests that optimizing sleep may be one way to maximize the effectiveness of treatments for depression such as psychotherapy.

Another study of 4,175 individuals between 11 and 17 years of age is the first to document reciprocal effects for major depression and short sleep duration among adolescents using prospective data. Results suggest sleeping six hours or less per night increases the risk for major depression, which in turn increases the risk for decreased sleep among adolescents.

"These results are important because they suggest that sleep deprivation may be a precursor for major depression in adolescents, occurring before other symptoms of major depression and additional mood disorders," said principal investigator Dr. Robert E. Roberts, professor of behavioral sciences in the School of Public Health at the University of Texas Health Science Center in Houston, Texas. "Questions on sleep disturbance and hours of sleep should be part of the medical history of adolescents to ascertain risk."

The Centers for Disease Control and Prevention reports that about nine percent of adults in the U.S. meet the criteria for current depression, including four percent with major depression. The National Institute of Mental Health reports that depressive disorders have affected approximately 11 percent of U.S. teens at some point during their lives, and three percent have experienced a seriously debilitating depressive disorder.


'/>"/>
Contact: Lynn Celmer
lcelmer@aasmnet.org
630-737-9700
American Academy of Sleep Medicine
Source:Eurekalert  

Related medicine news :

1. JAX Genomic Medicines Jeffrey Chuang, Ph.D., receives $519,750 grant for RNA studies
2. Cedars-Sinai clinical trial studies vaccine targeting cancer stem cells in brain cancers
3. Risperdal Lawsuit News: Rottenstein Law Group LLP Comments on Plaintiffs’ Request to Unseal Key Clinical Studies Data
4. Risperdal Lawsuits Progress, as Bernstein Liebhard LLP Notes Filing of Plaintiff Brief Seeking to Unseal Risperdal Clinical Studies
5. As Risperdal Lawsuits Move Forward, Wright & Schulte LLC Learns of Bid to Keep Clinical Studies Sealed in Pennsylvania Risperdal Litigation
6. Studies assess impact of IOM report on nursing reforms
7. Not in the mood but want to be? New studies bring women hope
8. End-Year Special Offer on Research Studies by Current Partnering Now Available at MarketPublishers.com
9. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Johnson & Johnson Bid to Keep Clinical Studies Under Seal
10. The importance of standardizing drug screening studies
11. Diet Doc Hormone Diets & Weight Loss Plans Announces New Diet Plans Helping Women Lose Excess Fat Prior to Pregnancy, Which Studies Show Leads to Fewer Complications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies find new links between sleep duration and depression
(Date:4/27/2017)... ... , ... Offering the purest product of its kind, Swissx Labs AG has ... than the market has seen before. Swissx uses proprietary strains of hemp plants grown ... process for extraction, to produce its CBD oil--maximizing its benefits for health and wellness. ...
(Date:4/26/2017)... ... 2017 , ... Journal of Oral Implantology – Tooth loss is ... dental health, including complications with speech, eating, and overcompensation of mouth due to the ... teeth. As the number of tooth replacements increase, it is imperative to design an ...
(Date:4/26/2017)... ... April 26, 2017 , ... The National Business Research ... National Registry of Emergency Medical Technicians and welcomes this organization to the ... Jan G. West, Ph.D. , CEO & Organizational Psychologist at NBRI. “This award ...
(Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® ... ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. “Soy ... cost savings as well as more stable pricing over time. Now it’s even ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... an agreement to be the preferred physical therapy provider for Derby City CrossFit, ... to Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces ... Investor Conference 2017 at the Sheraton Hotel in Toronto, ... Officer of the Company is scheduled to present on Tuesday, May ... and the Chairman of the Board, Tony Holler will ... For ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... research provides evidence that an old drug may provide relief ... today that will be presented at the American Academy ... , April 22 to 28, 2017. ... oral drug levodopa has long been considered the gold standard, ... progresses, the effects of the medication can partially wear off ...
Breaking Medicine Technology: